Hyperparathyroidism screening: Difference between revisions

	Hyperparathyroidism Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Hyperparathyroidism from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Hyperparathyroidism screening On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Hyperparathyroidism screening All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Hyperparathyroidism screening
CDC on Hyperparathyroidism screening
Hyperparathyroidism screening in the news
Blogs on Hyperparathyroidism screening
Directions to Hospitals Treating Hyperparathyroidism
Risk calculators and risk factors for Hyperparathyroidism screening

Revision as of 13:35, 30 August 2017

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Anmol Pitliya, M.B.B.S. M.D.[2]

There is insufficient evidence to recommend routine screening for hyperparathyroidism.

There is insufficient evidence to recommend routine screening for hyperparathyroidism.

@@ Line 2: / Line 2: @@
 {{Hyperparathyroidism}}
-{{CMG}}; {{AE}}
+{{CMG}}; {{AE}} {{Anmol}}
 ==Overview==
-*There is insufficient evidence to recommend routine screening for [disease/malignancy].
+There is insufficient evidence to recommend routine screening for hyperparathyroidism.
-OR
-*According to the [guideline name], screening for [disease name] is not recommended.
-OR
-*According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3].
 ==Screening==
-*There is insufficient evidence to recommend routine screening for [disease/malignancy].
+There is insufficient evidence to recommend routine screening for hyperparathyroidism.
-OR
-*According to the [guideline name], screening for [disease name] is not recommended.
-OR
-*According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with:
-**[condition 1]
-**[condition 2]
-**[condition 3]
 ==References==